ID   SFR19_HUMAN             Reviewed;        1312 AA.
AC   Q9H7N4; Q7Z5V7; Q8WVA1; Q9NR59;
DT   11-SEP-2007, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 3.
DT   28-JUN-2023, entry version 146.
DE   RecName: Full=Splicing factor, arginine/serine-rich 19;
DE   AltName: Full=SR-related C-terminal domain-associated factor 1;
DE            Short=SR-related and CTD-associated factor 1;
DE   AltName: Full=SR-related-CTD-associated factor;
DE            Short=SCAF;
DE   AltName: Full=Serine arginine-rich pre-mRNA splicing factor SR-A1;
DE            Short=SR-A1;
GN   Name=SCAF1; Synonyms=SFRS19, SRA1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], INDUCTION, AND TISSUE SPECIFICITY.
RX   PubMed=11461075; DOI=10.1054/bjoc.2001.1885;
RA   Scorilas A., Kyriakopoulou L., Katsaros D., Diamandis E.P.;
RT   "Cloning of a gene (SR-A1), encoding for a new member of the human Ser/Arg-
RT   rich family of pre-mRNA splicing factors: overexpression in aggressive
RT   ovarian cancer.";
RL   Br. J. Cancer 85:190-198(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Spleen;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Eye, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   TISSUE SPECIFICITY.
RX   PubMed=15493872; DOI=10.1515/bc.2004.102;
RA   Mathioudaki K., Leotsakou T., Papadokostopoulou A., Paraskevas E.,
RA   Ardavanis A., Talieri M., Scorilas A.;
RT   "SR-A1, a member of the human pre-mRNA splicing factor family, and its
RT   expression in colon cancer progression.";
RL   Biol. Chem. 385:785-790(2004).
RN   [5]
RP   INTERACTION WITH POLR2A.
RX   PubMed=15992770; DOI=10.1016/j.bbrc.2005.06.053;
RA   Katsarou M.E., Papakyriakou A., Katsaros N., Scorilas A.;
RT   "Expression of the C-terminal domain of novel human SR-A1 protein:
RT   interaction with the CTD domain of RNA polymerase II.";
RL   Biochem. Biophys. Res. Commun. 334:61-68(2005).
RN   [6]
RP   TISSUE SPECIFICITY.
RX   PubMed=16631123; DOI=10.1016/j.bbrc.2006.03.184;
RA   Leoutsakou T., Talieri M., Scorilas A.;
RT   "Expression analysis and prognostic significance of the SRA1 gene, in
RT   ovarian cancer.";
RL   Biochem. Biophys. Res. Commun. 344:667-674(2006).
RN   [7]
RP   TISSUE SPECIFICITY.
RX   PubMed=17132108; DOI=10.1515/bc.2006.201;
RA   Leoutsakou T., Talieri M., Scorilas A.;
RT   "Prognostic significance of the expression of SR-A1, encoding a novel SR-
RT   related CTD-associated factor, in breast cancer.";
RL   Biol. Chem. 387:1613-1618(2006).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-526; SER-738 AND SER-874, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-498; SER-500; SER-734 AND
RP   SER-738, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein phosphorylation
RT   analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-239; SER-498; SER-500;
RP   SER-734; SER-738; SER-965 AND THR-989, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-239; SER-448; SER-453;
RP   SER-498; SER-500; SER-548; SER-734; SER-738 AND SER-965, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-239; SER-498; SER-500;
RP   SER-548; SER-734; SER-738; SER-874; SER-965; THR-976 AND THR-1001, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-239; SER-498; SER-500;
RP   SER-612; SER-614; SER-734; SER-738; SER-874; SER-929; SER-936; SER-965 AND
RP   THR-1001, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-239; SER-498; SER-500;
RP   SER-548; THR-706; SER-719; SER-725; SER-734; SER-738; SER-872; SER-874;
RP   SER-965; THR-976 AND THR-989, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-239; THR-335; SER-498;
RP   SER-500; TYR-732; SER-734; SER-738; SER-874 AND THR-989, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [17]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-865, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: May function in pre-mRNA splicing. {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with POLR2A. {ECO:0000269|PubMed:15992770}.
CC   -!- INTERACTION:
CC       Q9H7N4; Q99828: CIB1; NbExp=5; IntAct=EBI-1222181, EBI-372594;
CC       Q9H7N4; O15499: GSC2; NbExp=3; IntAct=EBI-1222181, EBI-19954058;
CC       Q9H7N4; Q6FHY5: MEOX2; NbExp=3; IntAct=EBI-1222181, EBI-16439278;
CC       Q9H7N4; Q765P7: MTSS2; NbExp=3; IntAct=EBI-1222181, EBI-2815102;
CC       Q9H7N4; Q8WWV3: RTN4IP1; NbExp=3; IntAct=EBI-1222181, EBI-743502;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Highly expressed in fetal brain and
CC       liver, poorly expressed in salivary gland, heart, skin and ovary.
CC       Expressed in colorectal carcinomas and ovarian cancers. Overexpressed
CC       in colorectal carcinomas as compared to normal colonic mucosa.
CC       {ECO:0000269|PubMed:11461075, ECO:0000269|PubMed:15493872,
CC       ECO:0000269|PubMed:16631123, ECO:0000269|PubMed:17132108}.
CC   -!- INDUCTION: Up-regulated by estrogens, androgens and glucocorticoids.
CC       {ECO:0000269|PubMed:11461075}.
CC   -!- SIMILARITY: Belongs to the splicing factor SR family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB15734.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="https://atlasgeneticsoncology.org/gene/46074/SCAF1";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF254411; AAF87552.1; -; Genomic_DNA.
DR   EMBL; AK024444; BAB15734.1; ALT_INIT; mRNA.
DR   EMBL; BC018398; AAH18398.1; -; mRNA.
DR   EMBL; BC053992; AAH53992.1; -; mRNA.
DR   CCDS; CCDS33074.1; -.
DR   RefSeq; NP_067051.2; NM_021228.2.
DR   RefSeq; XP_005259179.1; XM_005259122.4.
DR   AlphaFoldDB; Q9H7N4; -.
DR   SMR; Q9H7N4; -.
DR   BioGRID; 121834; 120.
DR   IntAct; Q9H7N4; 44.
DR   MINT; Q9H7N4; -.
DR   STRING; 9606.ENSP00000353769; -.
DR   GlyCosmos; Q9H7N4; 2 sites, 1 glycan.
DR   GlyGen; Q9H7N4; 3 sites, 1 O-linked glycan (3 sites).
DR   iPTMnet; Q9H7N4; -.
DR   PhosphoSitePlus; Q9H7N4; -.
DR   SwissPalm; Q9H7N4; -.
DR   BioMuta; SCAF1; -.
DR   DMDM; 296452955; -.
DR   EPD; Q9H7N4; -.
DR   jPOST; Q9H7N4; -.
DR   MassIVE; Q9H7N4; -.
DR   MaxQB; Q9H7N4; -.
DR   PaxDb; Q9H7N4; -.
DR   PeptideAtlas; Q9H7N4; -.
DR   ProteomicsDB; 81132; -.
DR   ABCD; Q9H7N4; 7 sequenced antibodies.
DR   Antibodypedia; 32077; 87 antibodies from 18 providers.
DR   Ensembl; ENST00000360565.8; ENSP00000353769.2; ENSG00000126461.15.
DR   GeneID; 58506; -.
DR   KEGG; hsa:58506; -.
DR   MANE-Select; ENST00000360565.8; ENSP00000353769.2; NM_021228.3; NP_067051.2.
DR   UCSC; uc002poq.4; human.
DR   AGR; HGNC:30403; -.
DR   CTD; 58506; -.
DR   DisGeNET; 58506; -.
DR   GeneCards; SCAF1; -.
DR   HGNC; HGNC:30403; SCAF1.
DR   HPA; ENSG00000126461; Low tissue specificity.
DR   MIM; 617264; gene.
DR   neXtProt; NX_Q9H7N4; -.
DR   OpenTargets; ENSG00000126461; -.
DR   PharmGKB; PA162402459; -.
DR   VEuPathDB; HostDB:ENSG00000126461; -.
DR   eggNOG; KOG0825; Eukaryota.
DR   GeneTree; ENSGT00950000183205; -.
DR   HOGENOM; CLU_006936_0_0_1; -.
DR   InParanoid; Q9H7N4; -.
DR   OMA; ADTRWGG; -.
DR   OrthoDB; 5407065at2759; -.
DR   PhylomeDB; Q9H7N4; -.
DR   TreeFam; TF332183; -.
DR   PathwayCommons; Q9H7N4; -.
DR   SignaLink; Q9H7N4; -.
DR   BioGRID-ORCS; 58506; 199 hits in 1158 CRISPR screens.
DR   ChiTaRS; SCAF1; human.
DR   GenomeRNAi; 58506; -.
DR   Pharos; Q9H7N4; Tbio.
DR   PRO; PR:Q9H7N4; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; Q9H7N4; protein.
DR   Bgee; ENSG00000126461; Expressed in sural nerve and 118 other tissues.
DR   ExpressionAtlas; Q9H7N4; baseline and differential.
DR   Genevisible; Q9H7N4; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0019904; F:protein domain specific binding; IEA:Ensembl.
DR   GO; GO:0003723; F:RNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0099122; F:RNA polymerase II C-terminal domain binding; IPI:UniProtKB.
DR   GO; GO:0006397; P:mRNA processing; IEA:UniProtKB-KW.
DR   GO; GO:0008380; P:RNA splicing; IEA:UniProtKB-KW.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; IEA:Ensembl.
DR   InterPro; IPR042841; SCAF1.
DR   PANTHER; PTHR47013; SPLICING FACTOR, ARGININE/SERINE-RICH 19; 1.
DR   PANTHER; PTHR47013:SF1; SPLICING FACTOR, ARGININE/SERINE-RICH 19; 1.
DR   PRINTS; PR01217; PRICHEXTENSN.
PE   1: Evidence at protein level;
KW   Isopeptide bond; mRNA processing; mRNA splicing; Nucleus; Phosphoprotein;
KW   Reference proteome; Repeat; RNA-binding; Ubl conjugation.
FT   CHAIN           1..1312
FT                   /note="Splicing factor, arginine/serine-rich 19"
FT                   /id="PRO_0000299406"
FT   REGION          1..85
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          157..349
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          408..1086
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1137..1209
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1187..1312
FT                   /note="Necessary for interaction with the CTD domain of
FT                   POLR2A"
FT   REGION          1277..1312
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        54..74
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        157..173
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        183..227
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        266..289
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        293..315
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        322..336
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        426..440
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        478..497
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        551..566
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        567..613
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        627..650
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        733..752
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        764..797
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        815..832
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        866..885
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        896..926
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        934..959
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        976..990
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1019..1041
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1042..1064
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1194..1209
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1287..1312
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         239
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         335
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         448
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19690332"
FT   MOD_RES         453
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19690332"
FT   MOD_RES         498
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16964243,
FT                   ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:19690332,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   MOD_RES         500
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16964243,
FT                   ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:19690332,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   MOD_RES         526
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17081983"
FT   MOD_RES         548
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19690332,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:23186163"
FT   MOD_RES         612
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692"
FT   MOD_RES         614
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692"
FT   MOD_RES         706
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         719
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         725
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         732
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         734
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16964243,
FT                   ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:19690332,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   MOD_RES         738
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16964243,
FT                   ECO:0007744|PubMed:17081983, ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         872
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         874
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17081983,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   MOD_RES         929
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692"
FT   MOD_RES         936
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692"
FT   MOD_RES         963
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5U4C3"
FT   MOD_RES         965
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163"
FT   MOD_RES         976
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         989
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   MOD_RES         992
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5U4C3"
FT   MOD_RES         1001
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692"
FT   CROSSLNK        865
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   VARIANT         895
FT                   /note="T -> A (in dbSNP:rs3745470)"
FT                   /id="VAR_052235"
FT   VARIANT         1146
FT                   /note="M -> T (in dbSNP:rs2304208)"
FT                   /id="VAR_052236"
FT   CONFLICT        420
FT                   /note="T -> P (in Ref. 2; BAB15734 and 3; AAH53992)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1312 AA;  139270 MW;  0CB1C87C963C52BD CRC64;
     MEEEDESRGK TEESGEDRGD GPPDRDPTLS PSAFILRAIQ QAVGSSLQGD LPNDKDGSRC
     HGLRWRRCRS PRSEPRSQES GGTDTATVLD MATDSFLAGL VSVLDPPDTW VPSRLDLRPG
     ESEDMLELVA EVRIGDRDPI PLPVPSLLPR LRAWRTGKTV SPQSNSSRPT CARHLTLGTG
     DGGPAPPPAP SSASSSPSPS PSSSSPSPPP PPPPPAPPAP PAPRFDIYDP FHPTDEAYSP
     PPAPEQKYDP FEPTGSNPSS SAGTPSPEEE EEEEEEEEEE EEDEEEEEGL SQSISRISET
     LAGIYDDNSL SQDFPGDESP RPDAQPTQPT PAPGTPPQVD STRADGAMRR RVFVVGTEAE
     ACREGKVSVE VVTAGGAALP PPLLPPGDSE IEEGEIVQPE EEPRLALSLF RPGGRAARPT
     PAASATPTAQ PLPQPPAPRA PEGDDFLSLH AESDGEGALQ VDLGEPAPAP PAADSRWGGL
     DLRRKILTQR RERYRQRSPS PAPAPAPAAA AGPPTRKKSR RERKRSGEAK EAASSSSGTQ
     PAPPAPASPW DSKKHRSRDR KPGSHASSSA RRRSRSRSRS RSTRRRSRST DRRRGGSRRS
     RSREKRRRRR RSASPPPATS SSSSSRRERH RGKHRDGGGS KKKKKRSRSR GEKRSGDGSE
     KAPAPAPPPS GSTSCGDRDS RRRGAVPPSI QDLTDHDLFA IKRTITVGRL DKSDPRGPSP
     APASSPKREV LYDSEGLSGE ERGGKSSQKD RRRSGAASSS SSSREKGSRR KALDGGDRDR
     DRDRDRDRDR SSKKARPPKE SAPSSGPPPK PPVSSGSGSS SSSSSCSSRK VKLQSKVAVL
     IREGVSSTTP AKDAASAGLG SIGVKFSRDR ESRSPFLKPD ERAPTEMAKA APGSTKPKKT
     KVKAKAGAKK TKGTKGKTKP SKTRKKVRSG GGSGGSGGQV SLKKSKADSC SQAAGTKGAE
     ETSWSGEERA AKVPSTPPPK AAPPPPALTP DSQTVDSSCK TPEVSFLPEE ATEEAGVRGG
     AEEEEEEEEE EEEEEEEEEQ QPATTTATST AAAAPSTAPS AGSTAGDSGA EDGPASRVSQ
     LPTLPPPMPW NLPAGVDCTT SGVLALTALL FKMEEANLAS RAKAQELIQA TNQILSHRKP
     PSSLGMTPAP VPTSLGLPPG PSSYLLPGSL PLGGCGSTPP TPTGLAATSD KREGSSSSEG
     RGDTDKYLKK LHTQERAVEE VKLAIKPYYQ KKDITKEEYK DILRKAVHKI CHSKSGEINP
     VKVSNLVRAY VQRYRYFRKH GRKPGDPPGP PRPPKEPGPP DKGGPGLPLP PL
//
